Abstract
Altered DNA methylation (DNAm) patterns of discoidin domain receptor 1 (DDR1) have been found in the blood and brain of patients with schizophrenia (SCZ) and the brain of patients with bipolar disorder (BD). Childhood trauma (CT) is associated with changes in DNAm that in turn are related to suicidal behavior (SB) in patients with several psychiatric disorders. Here, using MassARRAY® technology, we studied 128 patients diagnosed with BD in remission and 141 healthy controls (HCs) to compare leukocyte DDR1 promoter DNAm patterns between patients and HCs and between patients with and without SB. Additionally, we investigated whether CT was associated with DDR1 DNAm and mediated SB. We found hypermethylation at DDR1 cg19215110 and cg23953820 sites and hypomethylation at cg14279856 and cg03270204 sites in patients with BD compared to HCs. Logistic regression models showed that hypermethylation of DDR1 cg23953820 but not cg19215110 and CT were risk factors for BD, while cg14279856 and cg03270204 hypomethylation were protective factors. In patients, CT was a risk factor for SB, but DDR1 DNAm, although associated with CT, did not mediate the association of CT with SB. This is the first study demonstrating altered leukocyte DDR1 promoter DNAm in euthymic patients with BD. We conclude that altered DDR1 DNAm may be related to immune and inflammatory mechanisms and could be a potential blood biomarker for the diagnosis and stratification of psychiatric patients.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
The dataset supporting the conclusions of this article is available from the corresponding author upon reasonable request. All packages used in the data analysis were identified to ensure full reproducibility.
References
Vilella E, Gas C, Garcia-Ruiz B, Rivera FJ. Expression of DDR1 in the CNS and in myelinating oligodendrocytes. Biochim Biophys acta Mol cell Res. 2019;1866:118483. https://doi.org/10.1016/j.bbamcr.2019.04.010.
Corty MM, Hulegaard AL, Hill JQ, Sheehan AE, Aicher SA, Freeman MR. Discoidin domain receptor regulates ensheathment, survival and caliber of peripheral axons. Development. 2022;149:dev200636. https://doi.org/10.1242/dev.200636.
Muntané G, Chillida M, Aranda S, Navarro A, Vilella E. Coexpression of the discoidin domain receptor 1 gene with oligodendrocyte-related and schizophrenia risk genes in the developing and adult human brain. Brain Behav. 2021;11:1–10. https://doi.org/10.1002/brb3.2309.
Roig B, Abasolo N, Moyano S, Martorell L, Vilella E. Increased expression of the spliced DDR1c isoform in brain tissues from schizophrenia patients. J Psychiatr Res. 2012;46:825–7.
Franco-Pons N, Tomas J, Roig B, Auladell C, Martorell L, Vilella E. Discoidin domain receptor 1, a tyrosine kinase receptor, is upregulated in an experimental model of remyelination and during oligodendrocyte differentiation in vitro. J Mol Neurosci. 2009;38:2–11. https://doi.org/10.1007/s12031-008-9151-x.
Franco-Pons N, Virgos C, Vogel WF, Urena JM, Soriano E, del Rio JA. et al. Expression of discoidin domain receptor 1 during mouse brain development follows the progress of myelination. Neuroscience. 2006;140:463–75. https://doi.org/10.1016/j.neuroscience.2006.02.033.
Garcia-Ruiz B, De Moura MC, Muntané G, Martorell L, Bosch E, Esteller M. et al. DDR1 methylation is associated with bipolar disorder and the isoform expression and methylation of myelin genes. Epigenomics. 2021;13:845–58. https://doi.org/10.2217/epi-2021-0006.
Garcia-Ruiz B, Moreno L, Muntané G, Sánchez-Gistau V, Gutiérrez-Zotes A, Martorell L. et al. Leukocyte and brain DDR1 hypermethylation is altered in psychosis and is correlated with stress and inflammatory markers. Epigenomics. 2020;12:251–65. https://doi.org/10.2217/epi-2019-0191.
Canales-Rodríguez EJ, Pomarol-Clotet E, Radua J, Sarró S, Alonso-Lana S, Del Mar Bonnín C. et al. Structural abnormalities in bipolar euthymia: A multicontrast molecular diffusion imaging study. Biol Psychiatry. 2014;76:239–48. https://doi.org/10.1016/j.biopsych.2013.09.027.
Favre P, Pauling M, Stout J, Hozer F, Sarrazin S, Abé C. et al. Widespread white matter microstructural abnormalities in bipolar disorder: evidence from mega- and meta-analyses across 3033 individuals. Neuropsychopharmacology. 2019;44:2285–93. https://doi.org/10.1038/s41386-019-0485-6.
Poletti S, Bollettini I, Lorenzi C, Vitali A, Brioschi S, Serretti A. et al. White Matter Microstructure in Bipolar Disorder Is Influenced by the Interaction between a Glutamate Transporter EAAT1 Gene Variant and Early Stress. Mol Neurobiol. 2019;56:702–10. https://doi.org/10.1007/s12035-018-1117-6.
Tkachev D, Mimmack ML, Ryan MM, Wayland M, Freeman T, Jones PB. et al. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet. 2003;362:798–805. https://doi.org/10.1016/S0140-6736(03)14289-4.
Gordovez FJA, McMahon FJ. The genetics of bipolar disorder. Mol Psychiatry. 2020;25:544–59. https://doi.org/10.1038/s41380-019-0634-7.
Mullins N, Forstner AJ, O’Connell KS, Coombes B, Coleman JRI, Qiao Z. et al. Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology. Nat Genet. 2021;53:817–29. https://doi.org/10.1038/s41588-021-00857-4.
Hara T, Owada Y, Takata A. Genetics of bipolar disorder: insights into its complex architecture and biology from common and rare variants. J Hum Genet. 2023;68:183–91. https://doi.org/10.1038/s10038-022-01046-9.
Arsenault-Lapierre G, Kim C, Turecki G. Psychiatric diagnoses in 3275 suicides: A meta-analysis. BMC Psychiatry. 2004;4:1–11. https://doi.org/10.1186/1471-244X-4-37.
Miller JN, Black DW. Bipolar Disorder and Suicide: a Review. Curr Psychiatry Rep. 2020;22:6. https://doi.org/10.1007/s11920-020-1130-0.
Plans L, Barrot C, Nieto E, Rios J, Schulze TG, Papiol S, et al. Association between completed suicide and bipolar disorder: A systematic review of the literature. J Affect Disord. 2019;242:111–22. https://doi.org/10.1016/j.jad.2018.08.054.
Palmier-Claus JE, Berry K, Bucci S, Mansell W, Varese F. Relationship between childhood adversity and bipolar affective disorder: systematic review and meta-analysis. Br J Psychiatry. 2016;209:454–9. https://doi.org/10.1192/bjp.bp.115.179655.
Kessler RC, McLaughlin KA, Green JG, Gruber MJ, Sampson NA, Zaslavsky AM, et al. Childhood adversities and adult psychopathology in the WHO world mental health surveys. Br J Psychiatry. 2010;197:378–85. https://doi.org/10.1192/BJP.BP.110.080499.
Sahle BW, Reavley NJ, Li W, Morgan AJ, Yap MBH, Reupert A, et al. The association between adverse childhood experiences and common mental disorders and suicidality: an umbrella review of systematic reviews and meta-analyses. Eur Child Adolesc Psychiatry. 2022;31:1489–99. https://doi.org/10.1007/s00787-021-01745-2.
Parade SH, Huffhines L, Daniels TE, Stroud LR, Nugent NR, Tyrka AR. A systematic review of childhood maltreatment and DNA methylation: candidate gene and epigenome-wide approaches. Transl Psychiatry. 2021;11:134. https://doi.org/10.1038/s41398-021-01207-y.
Løkhammer S, Stavrum A, Polushina T, Aas M, Ottesen A, Andreassen O, et al. An epigenetic association analysis of childhood trauma in psychosis reveals possible overlap with methylation changes associated with PTSD. Transl Psychiatry. 2022;12:177. https://doi.org/10.1038/s41398-022-01936-8.
Fachim HA, Corsi-Zuelli F, Loureiro CM, Iamjan Sarun, Shuhama R, Joca S, et al. Early-life stress effects on BDNF DNA methylation in first-episode psychosis and in rats reared in isolation. Prog Neuro-Psychopharmacol Biol Psychiatry. 2021;108:110188. https://doi.org/10.1016/j.pnpbp.2020.110188.
Dunn EC, Soare TW, Zhu Y, Simpkin AJ, Suderman MJ, Klengel T, et al. Sensitive Periods for the Effect of Childhood Adversity on DNA Methylation: Results From a Prospective, Longitudinal Study. Biol Psychiatry. 2019;85:838–49. https://doi.org/10.1016/j.biopsych.2018.12.023.
Lutz PE, Mechawar N, Turecki G. Neuropathology of suicide: Recent findings and future directions. Mol Psychiatry. 2017;22:1395–412. https://doi.org/10.1038/mp.2017.141.
Turecki G, Meaney M. Effects of the social environment and stress on glucocorticoid receptor gene methylation: a systematic review. Biol Psychiatry. 2016;79:87–96. https://doi.org/10.1016/j.biopsych.2014.11.022.
McLaughlin KA, Sheridan MA, Nelson CA. Neglect as a Violation of Species-Expectant Experience: Neurodevelopmental Consequences. Biol Psychiatry. 2017;82:462–71. https://doi.org/10.1016/j.biopsych.2017.02.1096.
Montalvo-Ortiz JL. A New Perspective on the Mechanisms of Neglect. Biol Psychiatry. 2017;82:e49–50. https://doi.org/10.1016/j.biopsych.2017.07.013.
Salagre E, Arango C, Artigas F, Ayuso-Mateos JL, Bernardo M, Castro-Fornieles J, et al. CIBERSAM: Ten years of collaborative translational research in mental disorders. Rev Psiquiatr Salud Ment. 2019;12:1–8. https://doi.org/10.1016/j.rpsm.2018.10.001.
Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56–62. https://doi.org/10.1136/JNNP.23.1.56.
Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978;133:429–35. https://doi.org/10.1192/bjp.133.5.429.
Wechsler D. WAIS-III administration and scoring manual. San Anotnio, TX: The Psychological Corporation; 1997.
Leucht S, Samara M, Heres S, Patel MX, Woods SW, Davis JM. Dose equivalents for second-generation antipsychotics: The minimum effective dose method. Schizophr Bull. 2014;40:314–26. https://doi.org/10.1093/schbul/sbu001.
Rothe PH, Heres S, Leucht S. Dose equivalents for second generation long-acting injectable antipsychotics: The minimum effective dose method. Schizophr Res. 2018;193:23–8. https://doi.org/10.1016/j.schres.2017.07.033.
Posner K, Brown GK, Stanley B, Brent DA, Yershova KV, Oquendo MA, et al. The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry. 2011;168:1266–77. https://doi.org/10.1176/appi.ajp.2011.10111704.
Bernstein DP, Fink L. Childhood Trauma Questionnaire: A retrospective self-report manual. San Anotnio, TX: The Psychological Corporation; 1998.
Ehrich M, Nelson MR, Stanssens P, Zabeau M, Liloglou T, Xinarianos G, et al. Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. Proc Natl Acad Sci USA. 2005;102:15785–90. https://doi.org/10.1073/pnas.0507816102.
Roig B, Virgos C, Franco N, Martorell L, Valero J, Costas J, et al. The discoidin domain receptor 1 as a novel susceptibility gene for schizophrenia. Mol Psychiatry. 2007;12:833–41. https://doi.org/10.1038/sj.mp.4001995.
Gas C, Canales-Rodriguez EJ, Radua J, Abasolo N, Cortes MJ, Salvado E, et al. Discoidin domain receptor 1 gene variants are associated with decreased white matter fractional anisotropy and decreased processing speed in schizophrenia. J Psychiatr Res. 2019;110:74–82. https://doi.org/10.1016/j.jpsychires.2018.12.021.
Roig B, Moyano S, Martorell L, Costas J, Vilella E. The discoidin domain receptor 1 gene has a functional A2RE sequence. J Neurochem. 2012;120:408–18.
UCSC Genome Browser. http://genome.ucsc.edu.
Encyclopedia of DNA elements (ENCODE) project. https://www.encodeproject.org.
Lesurf R, Cotto KC, Wang G, Griffith M, Kasaian K, Jones SJM, et al. ORegAnno 3.0: A community-driven resource for curated regulatory annotation. Nucleic Acids Res. 2016;44:D126–32. https://doi.org/10.1093/nar/gkv1203.
R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2021. https://www.r-project.org/.
Wheeler RE, Torchiano M. lmPerm: Permutation tests for linear models. 2016. https://cran.r-project.org/package=lmPerm.
Fox J, Weisberg S. An {R} Companion to Applied Regression, Third Edition. Thousand Oaks, CA; 2019. https://socialsciences.mcmaster.ca/jfox/Books/Companion/.
Lele SR, Keim JL, Solymos P. ResourceSelection: Resource Selection (Probability) Functions for Use-Availability Data. 2019. https://cran.r-project.org/package=ResourceSelection.
Yu Q, Li B. mma: Multiple Mediation Analysis. 2021. https://cran.r-project.org/web/packages/mma/index.html.
Wickham H. Elegant Graphics for Data Analysis. New York: Springer-Verlag; 2016. https://ggplot2.tidyverse.org.
Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J R Stat Soc Ser B. 1995;57:289–300. https://doi.org/10.1111/j.2517-6161.1995.tb02031.x.
Igarashi H, Medina KL, Yokota T, Rossi MID, Sakaguchi N, Comp PC, et al. Early lymphoid progenitors in mouse and man are highly sensitive to glucocorticoids. Int Immunol. 2005;17:501–11. https://doi.org/10.1093/intimm/dxh230.
Chrousos GP. Stress, chronic inflammation, and emotional and physical well-being: Concurrent effects and chronic sequelae. J Allergy Clin Immunol. 2000;106:S275–91. https://doi.org/10.1067/mai.2000.110163.
Lu X, Chu CS, Fang T, Rayon-Estrada V, Fang F, Patke A, et al. MTA2/NuRD Regulates B Cell Development and Cooperates with OCA-B in Controlling the Pre-B to Immature B Cell Transition. Cell Rep. 2019;28:472–485.e5. https://doi.org/10.1016/j.celrep.2019.06.029.
Rybakowski JK. Lithium. Eur Neuropsychopharmacol. 2022;57:86–7. https://doi.org/10.1016/j.euroneuro.2022.01.111.
Fountoulakis KN, Tohen M, Zarate CA. Lithium treatment of Bipolar disorder in adults: A systematic review of randomized trials and meta-analyses. Eur Neuropsychopharmacol. 2022;54:100–15. https://doi.org/10.1016/j.euroneuro.2021.10.003.
Pisanu C, Meloni A, Severino G, Squassina A. Genetic and Epigenetic Markers of Lithium Response. Int J Mol Sci. 2022;23:1–23. https://doi.org/10.3390/ijms23031555.
Marie-Claire C, Lejeune FX, Mundwiller E, Ulveling D, Moszer I, Bellivier F, et al. A DNA methylation signature discriminates between excellent and non-response to lithium in patients with bipolar disorder type 1. Sci Rep. 2020;10:1–9. https://doi.org/10.1038/s41598-020-69073-0.
Viana J, Hannon E, Dempster E, Pidsley R, Macdonald R, Knox O, et al. Schizophrenia-associated methylomic variation: molecular signatures of disease and polygenic risk burden across multiple brain regions. Hum Mol Genet. 2017;26:210–25. https://doi.org/10.1093/hmg/ddw373.
Turecki G, Brent DA, Gunnell D, O’Connor RC, Oquendo MA, Pirkis J, et al. Suicide and suicide risk. Nat Rev Dis Prim. 2019;5:74. https://doi.org/10.1038/s41572-019-0121-0.
Clive ML, Boks MP, Vinkers CH, Osborne LM, Payne JL, Ressler KJ, et al. Discovery and replication of a peripheral tissue DNA methylation biosignature to augment a suicide prediction model. Clin Epigenet. 2016;8:1–14. https://doi.org/10.1186/s13148-016-0279-1.
Rice L, Waters CE, Eccles J, Garside H, Sommer P, Kay P, et al. Identification and functional analysis of SKA2 interaction with the glucocorticoid receptor. J Endocrinol. 2008;198:499–509. https://doi.org/10.1677/JOE-08-0019.
Guintivano J, Brown T, Newcomer A, Jones M, Cox O, Maher BS, et al. Identification and Replication of a Combined Epigenetic and Genetic Biomarker Predicting Suicide and Suicidal Behaviors. Am J Psychiatry. 2014;171:1287–96. https://doi.org/10.1176/appi.ajp.2014.14010008.
Kaminsky Z, Wilcox HC, Eaton WW, Van Eck K, Kilaru V, Jovanovic T, et al. Epigenetic and genetic variation at SKA2 predict suicidal behavior and post-traumatic stress disorder. Transl Psychiatry. 2015;5:627. https://doi.org/10.1038/tp.2015.105.
Sadeh N, Wolf EJ, Logue MW, Hayes JP, Stone A, Griffin LM, et al. Epigenetic variation at SKA2 predicts suicide phenotypes and internalizing psychopathology. Depress Anxiety. 2016;33:308–15. https://doi.org/10.1002/da.22480.
Moyon S, Huynh JL, Dutta D, Zhang F, Ma D, Yoo S, et al. Functional Characterization of DNA Methylation in the Oligodendrocyte Lineage. Cell Rep. 2016;15:748–60. https://doi.org/10.1016/j.celrep.2016.03.060.
Duarte D, Belzeaux R, Etain B, Greenway KT, Rancourt E, Correa H, et al. Childhood-maltreatment subtypes in bipolar patients with suicidal behavior: systematic review and meta-analysis. Braz J Psychiatry. 2020;42:558–67. https://doi.org/10.1590/1516-4446-2019-0592.
Segura AG, Mitjans M, Jiménez E, Fatjó-Vilas M, Ruiz V, Saiz PA, et al. Association of childhood trauma and genetic variability of CRH-BP and FKBP5 genes with suicidal behavior in bipolar patients. J Affect Disord. 2019;255:15–22. https://doi.org/10.1016/j.jad.2019.05.014.
Montoro I, Moreno L, Mulet P, Miró C, Leunda A, Llaurador-Coll M, et al. Maximal Sensitivity to Child Maltreatment at the Ages of 6 and 11 Years is Associated with the Risk of Bipolar Disorder. J Interpers Violence. 2023;38:3030–54. https://doi.org/10.1177/08862605221106128.
Schönfelder A, Hallensleben N, Spangenberg L, Forkmann T, Rath D, Glaesmer H. The role of childhood abuse for suicidality in the context of the interpersonal theory of suicide: An investigation in German psychiatric inpatients with depression. J Affect Disord. 2019;245:788–97. https://doi.org/10.1016/j.jad.2018.11.063.
Turecki G. The molecular bases of the suicidal brain. Nat Rev Neurosci. 2014;15:802–16. https://doi.org/10.1038/nrn3839.
Brewin CR, Andrews B, Gotlib IH. Psychopathology and early experience: a reappraisal of retrospective reports. Psychol Bull. 1993;113:82–98. https://doi.org/10.1037/0033-2909.113.1.82.
Hogg B, Valiente-Gómez A, Redolar-Ripoll D, Gardoki-Souto I, Fontana-McNally M, Lupo W, et al. High incidence of PTSD diagnosis and trauma-related symptoms in a trauma exposed bipolar I and II sample. Front psychiatry. 2022;13:931374 https://doi.org/10.3389/fpsyt.2022.931374.
Jones GH, Vecera CM, Pinjari OF, Machado-Vieira R. Inflammatory signaling mechanisms in bipolar disorder. J Biomed Sci. 2021;28:1–22. https://doi.org/10.1186/s12929-021-00742-6.
Rowland T, Perry BI, Upthegrove R, Barnes N, Chatterjee J, Gallacher D, et al. Neurotrophins, cytokines, oxidative stress mediators and mood state in bipolar disorder: Systematic review and meta-analyses. Br J Psychiatry. 2018;213:514–25. https://doi.org/10.1192/bjp.2018.144.
Acknowledgements
We are extremely grateful to all the subjects who participated in this study. We also thank the IISPV Biobank staff for their excellent work in the preparation and processing of the biological samples used in this study and for their technical support. This study was supported by grants from the Brain and Behavior Research Foundation (2017 NARSAD Independent grant, #25811 to El. V.), Instituto de Salud Carlos III (Research Project PI15/00852 and PI18/00945 to El. V., PI15/00283 to Ed. V.), Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM) (Intramural project grant to E Vieta) and Agència de Gestió d’Ajuts Universitaris i de Recerca (2017SGR00444 to El. V., 2017SGR01365 to Ed. V., 2017SGR01271 to E. P-C.). Selena Aranda was the recipient of a predoctoral fellowship granted by the Instituto de Salud Carlos III (PFIS FI19/00268), and Mar Fatjó-Vilas was the recipient of a Miguel Servet contract (CP20/00072; Instituto de Salud Carlos III; cofunded by the European Regional Development Fund (ERDF)/European Social Fund “Investing in your future”).
Author information
Authors and Affiliations
Contributions
ElV, EP-C, and EdV conceptualized and designed the study and provided funding acquisition, ethics approval, project administration, and resources. BG-R conceptualized and designed the study, performed DNA extraction, computed the statistical analyses, interpreted the results, produced the display items, and wrote the manuscript draft. ElV supervised the statistical analyses, interpreted the results, and wrote the manuscript draft. BG-R, EJ, SA, NV, AG-Z, CS, EL, SA-L, MF-V, SS, LlT, FP, and CM-B contributed to the recruitment of patients, collection and handling of blood samples, and acquisition and curation of research data. All the authors discussed the results, commented on the manuscript, and approved the final version for publication.
Corresponding author
Ethics declarations
Competing interests
EdV has received grants and served as consultant, advisor, or CME speaker (unrelated to this work) for the following entities: AB-Biotics, Abbott, AbbVie, Angelini, Biogen, Compass, Dainippon Sumitomo Pharma, Ferrer, Gedeon Richter, Glaxo Smith-Kline, GH Research, Janssen, Lundbeck, Otsuka, Sage, Sanofi-Aventis, Sunovion, Takeda, and Viatris. The other authors have no conflicts of interest to disclose.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Garcia-Ruiz, B., Jiménez, E., Aranda, S. et al. Associations of altered leukocyte DDR1 promoter methylation and childhood trauma with bipolar disorder and suicidal behavior in euthymic patients. Mol Psychiatry (2024). https://doi.org/10.1038/s41380-024-02522-8
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41380-024-02522-8